You’re using a public version of DrugChatter with 1 free searches available. Register to unlock more free searches per day. CREATE FREE ACCOUNT

Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Are there any special considerations for elderly patients taking cosentyx?



Cosentyx is a medication used to treat certain autoimmune diseases such as psoriasis and psoriatic arthritis. While there are no specific dosage recommendations for elderly patients, there are some considerations to keep in mind when prescribing this medication to this population. According to a study published in the Journal of the European Academy of Dermatology and Venereology [3], elderly patients may have a higher risk of infections due to age-related changes in the immune system. Therefore, it is important to monitor elderly patients taking Cosentyx for signs of infection and to take appropriate measures to prevent and treat infections.

Additionally, the Centers for Disease Control and Prevention (CDC) recommends that immunocompromised individuals, including elderly patients, take extra precautions when traveling to areas with a high risk of infection [2]. This is particularly important for patients taking medications like Cosentyx, which can suppress the immune system and increase the risk of infection. Elderly patients taking Cosentyx should consult with their healthcare provider before traveling to ensure that they are taking appropriate precautions.

In conclusion, while there are no specific dosage recommendations for elderly patients taking Cosentyx, healthcare providers should be aware of the potential increased risk of infections in this population. Elderly patients taking Cosentyx should be monitored closely for signs of infection and should take extra precautions when traveling to areas with a high risk of infection.

Sources:
[2] Centers for Disease Control and Prevention. (2021). Immunocompromised Travelers. Yellow Book. https://wwwnc.cdc.gov/travel/yellowbook/2024/additional-considerations/immunocompromised-travelers
[3] Naldi, L., & Stingeni, L. (2017). Safety and efficacy of secukinumab in elderly patients with moderate-to-severe plaque psoriasis. Journal of the European Academy of Dermatology and Venereology, 31(1), e4-e6. https://onlinelibrary.wiley.com/doi/10.1111/jdv.14454



Follow-up:   How does cosentyx affect elderly immune systems? Are there any increased risks for falls with cosentyx? Can cosentyx be safely used with other medications in elderly patients?





DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2024. All rights reserved.